{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:48:44Z","timestamp":1783698524875,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013700\/1"],"award-info":[{"award-number":["MR\/N013700\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>A comorbid diagnosis of a depressive disorder is a negative prognostic factor for individuals with AN, and novel treatments are needed to target depressive symptoms in this population. One emerging promising treatment for depressive disorders is ketamine, although there is less research investigating the use of ketamine for alleviating depression in people with AN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>This study reports on four patients with a lifetime diagnosis of AN and a comorbid diagnosis of major depressive disorder who received either intramuscular ketamine (<jats:italic>n<\/jats:italic> = 2) or intranasal esketamine (<jats:italic>n<\/jats:italic> = 2) treatment from a private psychiatric clinic. Depressive symptomatology (PHQ-9) was measured prior to (es)ketamine administration on every dosing session and adverse effects were recorded during and after dosing. All patients reported a subjective decrease in depression, although only those administered intranasal esketamine showed a reduction in PHQ-9 depression scores over time. Number of doses ranged from 3 to 23. All patients tolerated treatment well and no serious adverse effects emerged, however nausea\/vomiting was experienced by one patient on one dosing session. Weight remained stable in all cases, although notably across all patients, weight at the beginning of treatment was within a \u201chealthy\u201d range.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings suggest that (es)ketamine may reduce depressive symptoms in people with major depressive disorder and a comorbid diagnosis of AN. Future feasibility and pilot trials are warranted in order to elicit robust data on efficacy, acceptability, safety and tolerability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1181447","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:00:35Z","timestamp":1684159235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa"],"prefix":"10.3389","volume":"14","author":[{"given":"Johanna Louise","family":"Keeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Brendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1017\/S003329170100407X","article-title":"Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study","volume":"31","author":"L\u00f6we","year":"2001","journal-title":"Psychol Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/(SICI)1098-108X(200007)28:1&lt;20::AID-EAT3&gt;3.0.CO;2-X","article-title":"Mortality in eating disorders: a descriptive study","volume":"28","author":"Herzog","year":"2000","journal-title":"Int J Eating Disorders."},{"key":"B3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","article-title":"Risks of all-cause and suicide mortality in mental disorders: a meta-review","volume":"13","author":"Chesney","year":"2014","journal-title":"World Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.psychres.2015.09.008","article-title":"Psychiatric comorbidity in women and men with eating disorders results from a large clinical database","volume":"230","author":"Ulfvebrand","year":"2015","journal-title":"Psychiatry Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpsychires.2017.10.008","article-title":"Predictors of long-term recovery in anorexia nervosa and bulimia nervosa: data from a 22-year longitudinal study","volume":"96","author":"Franko","year":"2018","journal-title":"J Psychiatr Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40519-019-00686-9","article-title":"Early changes in depression predict outcomes of inpatient adolescent anorexia nervosa","volume":"25","author":"Kahn","year":"2020","journal-title":"Eating Weight Disorders Stud Anorexia Bulimia Obesity."},{"key":"B7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1037\/a0034010","article-title":"The role of affect in the maintenance of anorexia nervosa: evidence from a naturalistic assessment of momentary behaviors and emotion","volume":"122","author":"Engel","year":"2013","journal-title":"J Abnorm Psychol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.9740\/mhc.2018.05.127","article-title":"Role of antidepressants in the treatment of adults with anorexia nervosa","volume":"8","author":"Marvanova","year":"2018","journal-title":"Mental Health Clinician."},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Human Psychopharmacol Clin Exp."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review and meta-analysis","author":"Alnefeesi","year":"2022","journal-title":"J Psychiatr Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J Affect Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.genhosppsych.2015.01.003","article-title":"Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis","volume":"37","author":"Lee","year":"2015","journal-title":"Gen Hosp Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009\u2013January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J Affect Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int J Neuropsychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"Mcintyre","year":"2021","journal-title":"Am J Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","article-title":"Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review","volume":"8","author":"Walsh","year":"2022","journal-title":"BJPsych Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","article-title":"Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions","volume":"91","author":"Mills","year":"1998","journal-title":"QJM Monthly J Associat Phys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.3389\/fpsyt.2021.764112","article-title":"Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy","author":"Ragnhildstveit","year":"2021","journal-title":"Front Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","article-title":"Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report","volume":"11","author":"Scolnick","year":"2020","journal-title":"Front Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e03869","DOI":"10.1002\/ccr3.3869","article-title":"A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression","volume":"9","author":"Schwartz","year":"2021","journal-title":"Clin Case Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","article-title":"A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders","volume":"10","author":"Robison","year":"2022","journal-title":"J Eating Disorders."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40519-022-01455-x","article-title":"Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study","volume":"27","author":"Calabrese","year":"2022","journal-title":"Eating Weight Disorders Stud Anorexia Bulimia Obesity."},{"key":"B25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-016-1567-9","article-title":"Brain morphological changes in adolescent and adult patients with anorexia nervosa","volume":"123","author":"Seitz","year":"2016","journal-title":"J Neural Transm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.3390\/nu13114158","article-title":"Ketamine as a treatment for anorexia nervosa: a narrative review","volume":"13","author":"Keeler","year":"2021","journal-title":"Nutrients."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/17512433.2020.1850256","article-title":"Hippocampal volume, function, and related molecular activity in anorexia nervosa: a scoping review","volume":"13","author":"Keeler","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B28","volume-title":"Feeding and Eating Disorders. Diagnostic and Statistical Manual of Mental Disorders 5th ed","year":"2014"},{"key":"B29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2045125320916657","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Therapeutic Adv Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2016.05.007","article-title":"Potential involvement of serotonergic signaling in ketamine's antidepressant actions: a critical review","volume":"71","author":"Du Jardin","year":"2016","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.26502\/fjwhd.2644-28840044","article-title":"Ketamine in a patient with comorbid anorexia and MDD","volume":"3","author":"Dechant","year":"2020","journal-title":"J Womens Health Develop."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e021531","DOI":"10.1136\/bmjopen-2018-021531","article-title":"Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study","volume":"8","author":"Dalton","year":"2018","journal-title":"BMJ Open."},{"key":"B34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/erv.2766","article-title":"Repetitive transcranial magnetic stimulation treatment in severe, enduring anorexia nervosa: An open longer-term follow-up","volume":"28","author":"Dalton","year":"2020","journal-title":"Europ Eat Disorders Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"276","author":"Mcintyre","year":"2020","journal-title":"J Affect Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2023.2169349.","article-title":"Oral ketamine for depression: an updated systematic review","author":"Meshkat","year":"2023","journal-title":"World J Biol Psychiatry."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1111\/bcp.15374","article-title":"Ketamine treatment for refractory anxiety: a systematic review","volume":"88","author":"Tully","year":"2022","journal-title":"Br J Clin Pharmacol."},{"key":"B39","volume-title":"Beck Depression Inventory","author":"Beck","year":"1987"},{"key":"B40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1181447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:00:40Z","timestamp":1684159240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1181447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":40,"alternative-id":["10.3389\/fpsyt.2023.1181447"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1181447","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1181447"}}